Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jan;6(1):50-3.
doi: 10.1007/BF00856833.

Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma

Affiliations

Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma

M M Fitzpatrick et al. Pediatr Nephrol. 1992 Jan.

Abstract

There is evidence of neutrophil involvement in the pathogenesis of the haemolytic uraemic syndrome (HUS), and neutrophil release products are thought to cause endothelial cell damage. Elastase is the major lysosomal proteinase liberated by activated neutrophils. In this study we measured both free and complexed elastase. No free elastase activity could be detected in the plasma of patients with diarrhoea-associated (D+) HUS using a specific substrate. However, there was a marked increase in alpha 1-antitrypsin (alpha 1-AT) complexed elastase as measured by a newly developed enzyme-linked immunosorbent assay not only in D+ HUS, but also in non-diarrhoea-associated (D-) HUS. This finding is independent of either a high polymorphonuclear leucocyte count or renal failure. This increase in bound elastase together with our sequential data which demonstrate raised alpha 1-AT complexed elastase levels early in the disease process further support the theory that neutrophil activation is one of the key events in the pathophysiology of this disorder.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1986 Apr;77(4):1233-43 - PubMed
    1. J Clin Invest. 1987 Mar;79(3):669-74 - PubMed
    1. Lancet. 1989 Nov 11;2(8672):1153 - PubMed
    1. J Exp Med. 1988 Sep 1;168(3):1169-74 - PubMed
    1. Lancet. 1989 Aug 19;2(8660):411-4 - PubMed

Publication types